#obesity
Latest news and interesting information about obesity.
Will age restrictions on social networks work?
Proposal for 16+ age limit on social media: MP and psychologist opinions, potential effects, and parental responsibility.
Gallstones: Causes and Symptoms
Discover the causes, symptoms, and treatment of gallstones. Insights from surgeon Ruslan Ismayilov.
Live Lighter: Novo Nordisk in Azerbaijan
Novo Nordisk introduces new GLP-1 medication for obesity in Azerbaijan.
Benefits and Harms of Ice Cream Revealed
Discover the benefits and harms of ice cream as explained by dietitian Olga Yamilova.
Genentech to Present Obesity Drug Trial Data at ADA
Genentech presents Phase II data for obesity drugs enicepatide and petrelintide at ADA conference. Latest updates on weight loss treatments.
Beer alcoholism: the most insidious form
Learn about the symptoms and risks of beer alcoholism. A warning from a Russian psychologist.
S&P 500, Nasdaq hit record highs on Iran ceasefire
S&P 500, Nasdaq and Dow Jones hit record highs on US-Iran ceasefire news. Inflation data and AI stock rally support the market.
Entera Bio Presents Clinical Data on Osteoporosis Drug
Entera Bio presents clinical data for osteoporosis drug EB613. Presentation at ENDO 2026 conference.
Leerink Reaffirms Eli Lilly Stock Rating on Gene Therapy
Leerink reaffirms Eli Lilly stock rating with Outperform and $1,119 target, citing promising gene therapy data from VERVE-102 trial. Bond.az covers the latest.
Poolbeg Pharma Gets FDA Feedback on POLB 001
Poolbeg Pharma receives FDA feedback on POLB 001 for cancer immunotherapy-induced Cytokine Release Syndrome.
Pfizer SWOT analysis: new drugs
Pfizer SWOT analysis: new drugs Tukysa and anti-obesity strategy to navigate patent cliff.
Novo Nordisk Targets 2/3 Cut in Drug Launch Times with AI
Novo Nordisk aims to cut drug launch times by two-thirds using AI. Its Bengaluru center plays a key role in global launches.
Bernstein Initiates Neurocrine with Outperform Rating
Bernstein initiates Neurocrine Biosciences with an outperform rating and $221 price target. Highlights Crenessity's potential and stock upside.
Arecor Grants 455,000 Stock Options
Arecor Therapeutics grants 455,000 stock options to executives under Long Term Incentive Plan. Details on vesting, performance conditions.
Retatrutide Shows 28.3% Weight Loss
Eli Lilly's retatrutide achieves 28.3% weight loss in Phase 3 TRIUMPH-1 trial. New hope for obesity treatment.
Novo, Lilly weight-loss pills lure patients from compounded drugs
Lower prices for Novo Nordisk and Eli Lilly weight-loss pills are driving patients from compounded drugs to branded Wegovy and Foundayo, according to doctors.
Strawberry: best summer berry for heart health
Spanish cardiologist Aurelio Roxas reveals that strawberries are the best summer berry for heart health, thanks to antioxidants and fiber.
MeiraGTx CEO Forbes Alexandria sells $568,540 in shares
MeiraGTx CEO Forbes Alexandria sells $568,540 in shares. The stock has returned 66% over the past year but faces profitability challenges.
CBL-514: New Obesity Data Revealed
Caliway Biopharmaceuticals reveals new data on CBL-514 for obesity. Combination therapy boosts weight loss by 91.5%.
Safest Way to Lose Weight: Swimming
Safe weight loss method: swimming and aqua aerobics. Expert recommendations from Yekaterina Demyanovskaya.
"Wegovy" aids weight loss in menopause
"Wegovy" effectively supports weight loss and heart health in menopausal women.
...